[Dissemination of prostate cancer: a way paved of fat].

about

[Dissemination of prostate cancer: a way paved of fat].

Item

http://www.wikidata.org/entity/Q53067142

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

[Dissemination of prostate cancer: a way paved of fat].

@en

[Dissemination of prostate cancer: a way paved of fat].

@nl

type

Item

label

[Dissemination of prostate cancer: a way paved of fat].

@en

[Dissemination of prostate cancer: a way paved of fat].

@nl

prefLabel

[Dissemination of prostate cancer: a way paved of fat].

@en

[Dissemination of prostate cancer: a way paved of fat].

@nl

P1476

[Dissemination of prostate cancer: a way paved of fat]

@en

P2093

Adrien Guérard

http://www.w3.org/2001/XMLSchema#string

Aurélie Toulet

http://www.w3.org/2001/XMLSchema#string

Bernard Malavaud

http://www.w3.org/2001/XMLSchema#string

Catherine Muller

http://www.w3.org/2001/XMLSchema#string

Victor Laurent

http://www.w3.org/2001/XMLSchema#string

P2860

Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease

Cancer and the chemokine network

Adipokines in inflammation and metabolic disease

New chemokine targets for asthma therapy.

Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity

Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies

Extraprostatic extension into periprostatic fat is a more important determinant of prostate cancer recurrence than an invasive phenotype.

Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro.

Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients

P304

563-565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1051/MEDSCI/20163206012

http://www.w3.org/2001/XMLSchema#string

P407

Af-Faransiis

P433

6-7

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Valet

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27406759

http://www.w3.org/2001/XMLSchema#string